Pharmacotherapy of Attention-Deficit Hyperactivity Disorder in Adolescents

Drugs - 2012
Ann Childress1, Sally A. Berry2
1Center for Psychiatry and Behavioral Medicine, Inc, Las Vegas, USA
2NextWave Pharmaceuticals, Cupertino, USA

Tóm tắt

Từ khóa


Tài liệu tham khảo

, 2000

Molina, 2009 May, J Am Acad Child Adolesc Psychiatry, 48, 484, 10.1097/CHI.0b013e31819c23d0

Barkley, 1990 Jul, J Am Acad Child Adolesc Psychiatry, 29, 546, 10.1097/00004583-199007000-00007

Lara, 2009 Jan 1, Biol Psychiatry, 65, 46, 10.1016/j.biopsych.2008.10.005

Merikangas, 2010 Oct, J Am Acad Child Adolesc Psychiatry, 49, 980, 10.1016/j.jaac.2010.05.017

Nolan, 2001 Feb, J Am Acad Child Adolesc Psychiatry, 40, 241, 10.1097/00004583-200102000-00020

Bussing, 2010 Jun, J Am Acad Child Adolesc Psychiatry, 49, 595

Price, 2009 Sep, J Youth Adolesc, 38, 1059, 10.1007/s10964-008-9351-2

Brown, 2010 Aug, J Consult Clin Psychol, 78, 590, 10.1037/a0019632

Barkley, 2002, J Clin Psychiatry, 63, 10

Redelmeier, 2010, PLoS Med, 7, e1000369, 10.1371/journal.pmed.1000369

Pruitt, 1999

Biederman, 2008 Dec, J Dev Behav Pediatr, 29, 501, 10.1097/DBP.0b013e318190b290

Langley, 2010 Mar, Br J Psychiatry, 196, 235, 10.1192/bjp.bp.109.066274

Gau, 2007 Jan, Br J Psychiatry, 190, 42, 10.1192/bjp.bp.106.022871

Biederman, 1999 Aug, Pediatrics, 104, e20, 10.1542/peds.104.2.e20

Mannuzza, 2008 May, Am J Psychiatry, 165, 604, 10.1176/appi.ajp.2008.07091465

Biederman, 2009 Jul, Pediatrics, 124, 71, 10.1542/peds.2008-3347

Pliszka, 2007 Jul, J Am Acad Child Adolesc Psychiatry, 46, 894, 10.1097/chi.0b013e318054e724

Findling, 2011 Apr, J Am Acad Child Adolesc Psychiatry, 50, 395, 10.1016/j.jaac.2011.01.007

Spencer, 2006 Feb, Clin Ther, 28, 266, 10.1016/j.clinthera.2006.02.011

Greenhill, 2006 Jul, J Am Acad Child Adolesc Psychiatry, 45, 817, 10.1097/01.chi.0000220847.41027.5d

Findling, 2010 Jul, CNS Spectr, 15, 419, 10.1017/S1092852900000353

Wilens, 2006 Jan, Arch Pediatr Adolesc Med, 160, 82, 10.1001/archpedi.160.1.82

Greenhill, 2002 Mar, Pediatrics, 109, E39, 10.1542/peds.109.3.e39

Sallee, 2009 Feb, J Am Acad Child Adolesc Psychiatry, 48, 155, 10.1097/CHI.0b013e318191769e

Biederman, 2008 Jan, Pediatrics, 121, e73, 10.1542/peds.2006-3695

Wilens, 2012 Jan, J Am Acad Child Adolesc Psychiatry, 51, 74, 10.1016/j.jaac.2011.10.012

Jain, 2011 Feb, J Am Acad Child Adolesc Psychiatry, 50, 171, 10.1016/j.jaac.2010.11.005

Kollins, 2011 Jun, Pediatrics, 127, e1406, 10.1542/peds.2010-1260

Michelson, 2002, Am J Psychiatry, 159, 1896, 10.1176/appi.ajp.159.11.1896

Faraone, 2010 Apr, Eur Child Adolesc Psychiatry, 19, 353, 10.1007/s00787-009-0054-3

Pennick, 2010, Neuropsychiatr Dis Treat, 6, 317, 10.2147/NDT.S9749

Volkow, 2002, J Atten Disord, 6, S31, 10.1177/070674370200601S05

Brams, 2008, CNS Drugs, 22, 693, 10.2165/00023210-200822080-00006

Silva, 2008 Feb, J Am Acad Child Adolesc Psychiatry, 47, 199, 10.1097/chi.0b013e31815cd9a4

Silva, 2006 Jun, J Child Adolesc Psychopharmacol, 16, 239, 10.1089/cap.2006.16.239

Wilens, 2008 Jun, J Am Acad Child Adolesc Psychiatry, 47, 700, 10.1097/CHI.0b013e31816bffdf

McGough, 2006 Feb, J Atten Disord, 9, 476, 10.1177/1087054705284089

Newcorn, 2008 Jun, Am J Psychiatry, 165, 721, 10.1176/appi.ajp.2007.05091676

Wigal, 2005 Aug, J Atten Disord, 9, 275, 10.1177/1087054705281121

Hazell, 2011 Nov, J Atten Disord, 15, 674, 10.1177/1087054710379737

Dittmann, 2011 Apr, J Child Adolesc Psychopharmacol, 21, 97, 10.1089/cap.2009.0111

DellʼAgnello, 2009 Nov, Eur Neuropsychopharmacol, 19, 822, 10.1016/j.euroneuro.2009.07.008

Biederman, 2007 Jan, Psychopharmacology (Berl), 190, 31, 10.1007/s00213-006-0565-2

Newcorn, 2005 Mar, J Am Acad Child Adolesc Psychiatry, 44, 240, 10.1097/00004583-200503000-00008

Spencer, 2006 Mar, Clin Ther, 28, 402, 10.1016/j.clinthera.2006.03.006

Geller, 2007 Sep, J Am Acad Child Adolesc Psychiatry, 46, 1119, 10.1097/chi.0b013e3180ca8385

Thurstone, 2010 Jun, J Am Acad Child Adolesc Psychiatry, 49, 573

McRae-Clark, 2010 Nov-Dec, Am J Addict, 19, 481, 10.1111/j.1521-0391.2010.00076.x

Bangs, 2007 Aug, J Child Adolesc Psychopharmacol, 17, 407, 10.1089/cap.2007.0066

Allen, 2005 Dec 27, Neurology, 65, 1941, 10.1212/01.wnl.0000188869.58300.a7

Deputy, 2002 Nov-Dec, Clin Pediatr (Phila), 41, 736, 10.1177/000992280204100918

Castellanos, 1997 May, J Am Acad Child Adolesc Psychiatry, 36, 589, 10.1097/00004583-199705000-00008

Scahill, 2001 Jul, Am J Psychiatry, 158, 1067, 10.1176/appi.ajp.158.7.1067

McCracken, 2003 Jun, J Am Acad Child Adolesc Psychiatry, 42, 673, 10.1097/01.CHI.0000046863.56865.FE

Swanson, 2004 Mar, Pediatrics, 113, e206, 10.1542/peds.113.3.e206

Biederman, 2007 Nov 1, Biol Psychiatry, 62, 970, 10.1016/j.biopsych.2007.04.015

Wigal, 2009, Child Adolesc Psychiatry Ment Health, 3, 17, 10.1186/1753-2000-3-17

Wigal, 2011 Mar, Postgrad Med, 123, 169, 10.3810/pgm.2011.03.2275

Silva, 2008, Psychopharmacol Bull, 41, 19

Kelsey, 2004 Jul, Pediatrics, 114, e1, 10.1542/peds.114.1.e1

Hammerness, 2011 Oct, J Am Acad Child Adolesc Psychiatry, 50, 978, 10.1016/j.jaac.2011.07.018

Murray, 2008 Oct, Curr Psychiatry Rep, 10, 424, 10.1007/s11920-008-0068-4

Spencer, 2007 Oct, J Child Adolesc Psychopharmacol, 17, 689, 10.1089/cap.2006.0100

Sallee, 2009 Jun, J Child Adolesc Psychopharmacol, 19, 215, 10.1089/cap.2008.0080

Powers, 2008 Oct, J Child Adolesc Psychopharmacol, 18, 449, 10.1089/cap.2008.021

, 2010, MMWR Morb Mortal Wkly Rep, 59, 1439

Charach, 2004 May, J Am Acad Child Adolesc Psychiatry, 43, 559, 10.1097/00004583-200405000-00009